CD8A and neoplasm: For patients in this “activated group,” the tumor sample always had substantially higher compositions of T follicular helper cells, CD8+ T cells, regulatory T cells, and M1 and M2 macrophages (Fig. 3E; Fig. 11A, available as supplementary data at Bioinformatics online).